Anna Lundgren

4.7k citations
76 papers · 3.6k · h-index 33

Impact in

Papers in

  • Immunology 34
    • Immune Cell Function and Interaction 16
    • Galectins and Cancer Biology 7
    • T-cell and B-cell Immunology 7
  • Infectious Diseases 26
    • Viral gastroenteritis research and epidemiology 13
    • Viral Infections and Vectors 9
Co-authors
Ann‐Mari Svennerholm (27 shared papers)Anthony F. Barbet (16 shared papers)Karin Enarsson (6 shared papers)Elisabeth Suri‐Payer (3 shared papers)Björn Lundin (3 shared papers)Jooyoung Yi (5 shared papers)Guy H. Palmer (4 shared papers)Susannah Leach (11 shared papers)
Journals
Vaccine (14 papers)Infection and Immunity (13 papers)PLoS ONE (5 papers)Clinical Immunology (4 papers)Frontiers in Immunology (4 papers)
Partner nations
SwedenUnited StatesBangladesh

In The Last Decade

Anna Lundgren

76 papers receiving 3.5k citations

Peers

Anna Lundgren
Comparison fields: 5 of 102
  • Endocrinology 705
  • Parasitology 613
  • Immunology 1.4k
  • Infectious Diseases 1.0k
  • Microbiology 152
Replace Tatiane A. Paíxão with:
Tatiane A. Paíxão Brazil
Ralf Ignatius Germany
Jean‐Louis Mège France
G Duhamel United States
A. Baskerville United Kingdom
Francis W. Chandler United States
Herbert J. Van Kruiningen United States
Michael J. Lodes United States
Mariela Segura Canada
Mitchell V. Palmer United States
Anna Lundgren relative to Tatiane A. Paíxão Brazil Tatiane A. Paíxão's profile →
Citations per field
00.5×1.5×2×2.4×
Tatiane A. Paíxão · 1×
Citations per year

Countries citing papers authored by Anna Lundgren

Since Specialization
Citations

This map shows the geographic impact of Anna Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lundgren more than expected).

Fields of papers citing papers by Anna Lundgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lundgren. The network helps show where Anna Lundgren may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Lundgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Lundgren Line = papers co-authored together Anna Lundgren links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
PLoS Pathogens ·Ying‐Jie Lu, Jane A. Gross, Debby Bogaert, Adam Finn, Linda Bagrade, Qibo Zhang, Jay K. Kolls, Amit Srivastava, Anna Lundgren, Sophie Forte, Claudette M. Thompson, Kathleen F. Harney, Porter Anderson, Marc Lipsitch, Richard Malley
2008383
2
Helicobacter pylori - Specific CD4 + CD25 high Regulatory T Cells Suppress Memory T-Cell Responses to H . pylori in Infected Individuals
Infection and Immunity ·Anna Lundgren, Elisabeth Suri‐Payer, Karin Enarsson, Ann‐Mari Svennerholm, Björn Lundin
2003257
3
Mucosal FOXP3 -Expressing CD4 + CD25 high Regulatory T Cells in Helicobacter pylori -Infected Patients
Infection and Immunity ·Anna Lundgren, Erika Strömberg, Åsa Sjöling, Catharina Lindholm, Karin Enarsson, Anders Edebo, Erik Johnsson, Elisabeth Suri‐Payer, P. Larsson, Anna Rudin, Ann–Mari Svennerholm, Björn Lundin
2004216
4
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
Inflammatory Bowel Diseases ·Nathalie Holmén, Anna Lundgren, Samuel Lundin, Ann-Marie Bergin, Anna Rudin, Henrik Sjövall, Lena Öhman
2006149
5
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
PLoS ONE ·Emelie Marklund, Susannah Leach, Hannes Axelsson, Kristina Nystrôm, Heléne Norder, Mats Bemark, Davide Angeletti, Anna Lundgren, Staffan Nilsson, Lars‐Magnus Andersson, Aylin Yilmaz, Magnus Lindh, Jan‐Åke Liljeqvist, Magnus Gisslén
2020126
6
Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion
Molecular Microbiology ·Kelly A. Brayton, Guy H. Palmer, Anna Lundgren, Jooyoung Yi, Anthony F. Barbet
2002114
7
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
Vaccine ·Jan Holmgren, Louis Bourgeois, Nils Carlin, John D. Clements, Bjørn I. Gustafsson, Anna Lundgren, Erik Nygren, Joshua Tobias, Richard I. Walker, Ann‐Mari Svennerholm
2013110
8
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
Vaccine ·Anna Lundgren, Louis Bourgeois, Nils Carlin, John D. Clements, Björn Gustafsson, Marianne Hartford, Jan Holmgren, Max Petzold, Richard I. Walker, Ann–Mari Svennerholm
2014104
9
Antigenic Variation ofAnaplasma marginaleby Expression of MSP2 Mosaics
Infection and Immunity ·Anthony F. Barbet, Anna Lundgren, Jooyoung Yi, Fred R. Rurangirwa, Guy H. Palmer
2000100
10
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
The Lancet Infectious Diseases ·Firdausi Qadri, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, Mohiul Islam Chowdhury, Tasnuva Ahmed, Tanzeem Ahmed Rafique, Arifuzzaman Khan, Sadia Rahman, Farhana Khanam, Anna Lundgren, Gudrun Wiklund, Joanna Kaim, Madeleine Löfstrand, Nils Carlin, A. Louis Bourgeois, Nicole Maier, Alan Fix, Thomas F. Wierzba, Richard I. Walker, Ann–Mari Svennerholm
201989
11
Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma
Clinical Immunology ·Karin Enarsson, Anna Lundgren, Bert Kindlund, Mikael Hermansson, Giovanna Roncador, Alison H. Banham, B. Samuel Lundin, Marianne Quiding‐Järbrink
200687
12
Recent progress toward an enterotoxigenicEscherichia colivaccine
Expert Review of Vaccines ·Ann‐Mari Svennerholm, Anna Lundgren
201287
13
Expression of Multiple Outer Membrane Protein Sequence Variants from a Single Genomic Locus of Anaplasma phagocytophilum
Infection and Immunity ·Anthony F. Barbet, P. Meeus, Myriam Bélanger, Michael V. Bowie, Jooyoung Yi, Anna Lundgren, A. Rick Alleman, Susan J. Wong, Frederick K. Chu, Ulrike G. Munderloh, Steven D. Jauron
200384
14
A Controlled Study of Colonic Immune Activity and β7+ Blood T Lymphocytes in Patients With Irritable Bowel Syndrome
Clinical Gastroenterology and Hepatology ·Lena Öhman, (unknown), Anna Lundgren, M SIMREN, H SJOVALL
200581
15
CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells
European Journal of Immunology ·Kajsa Wing, Susanne Lindgrén, Gittan Kollberg, Anna Lundgren, Robert A. Harris, Anna Rudin, Samuel Lundin, Elisabeth Suri‐Payer
200380
16
Helicobacter pylori-Specific CD4+T Cells Home to and Accumulate in the HumanHelicobacter pylori-Infected Gastric Mucosa
Infection and Immunity ·Anna Lundgren, Christina Trollmo, Anders Edebo, Ann‐Mari Svennerholm, B. Samuel Lundin
200575
17
Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
Clinical and Vaccine Immunology ·Clayton Harro, Subhra Chakraborty, Andrea Feller, Barbara DeNearing, Alicia Cage, Malathi Ram, Anna Lundgren, Ann–Mari Svennerholm, A. Louis Bourgeois, Richard I. Walker, David A. Sack
201168
18
Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia
Infection and Immunity ·G Eid, Dorothy French, Anna Lundgren, Anthony F. Barbet, Terry F. McElwain, Guy H. Palmer
199662
19
Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP–Protein Kinase A and Inflammasome-Dependent IL-1 Signaling
The Journal of Immunology ·Maximilian Larena, Jan Holmgren, Michael Lebens, Manuela Terrinoni, Anna Lundgren
201560
20
The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens
PLoS ONE ·Susannah Leach, John D. Clements, Joanna Kaim, Anna Lundgren
201257

About Anna Lundgren

Anna Lundgren is a scholar working on Immunology, Infectious Diseases, Endocrinology, Parasitology and Surgery, having authored 76 papers that have together received 3.6k indexed citations. Recurring topics across this work include Escherichia coli research studies (22 papers), Vector-borne infectious diseases (16 papers), Immune Cell Function and Interaction (16 papers), Helicobacter pylori-related gastroenterology studies (14 papers), Viral gastroenteritis research and epidemiology (13 papers), Viral Infections and Vectors (9 papers), Galectins and Cancer Biology (7 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Endocrinology (705 citations), Parasitology (613 citations), Immunology (1.4k citations), Infectious Diseases (1.0k citations) and Microbiology (152 citations). Anna Lundgren has collaborated with scholars based in Sweden, United States and Bangladesh. Frequent co-authors include Ann‐Mari Svennerholm, Anthony F. Barbet, Karin Enarsson, Elisabeth Suri‐Payer, Björn Lundin, Jooyoung Yi, Guy H. Palmer, Susannah Leach, Anna Rudin and Samuel Lundin. Their work appears in journals such as Vaccine, Infection and Immunity, PLoS ONE, Clinical Immunology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatiane A. PaíxãoBreakdown of academic impact, for papers by Ralf IgnatiusBreakdown of academic impact, for papers by Jean‐Louis MègeBreakdown of academic impact, for papers by G DuhamelBreakdown of academic impact, for papers by A. BaskervilleBreakdown of academic impact, for papers by Francis W. ChandlerBreakdown of academic impact, for papers by Herbert J. Van KruiningenBreakdown of academic impact, for papers by Michael J. LodesBreakdown of academic impact, for papers by Mariela SeguraBreakdown of academic impact, for papers by Mitchell V. Palmer